document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align right small xecution small small ersion small style margin margin bottom font size font family time roman align center amendment research collaboration license agreement style margin margin bottom text indent font size font family time roman this amendment research collaboration license agreement this nbsp amendment entered into february nbsp between novartis institute biomedical research corporation organized existing under delaware with principal place business massachusetts avenue cambridge massachusetts alnylam pharmaceutical corporation organized existing under delaware with principal place business third street floor cambridge massachusetts style margin margin bottom font size font family time roman align center recital style margin margin bottom text indent font size font family time roman whereas alnylam novartis have previously entered into that certain research collaboration license agreement dated october nbsp amended those letter agreement dated nbsp april nbsp amended nbsp agreement style margin margin bottom text indent font size font family time roman whereas alnylam novartis desire amend certain term agreement forth this amendment style margin margin bottom text indent font size font family time roman therefore consideration respective representation warranty covenant agreement contained this amendment other valuable consideration receipt adequacy which hereby acknowledged alnylam novartis agree follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign definition term used this amendment otherwise defined this amendment will have same meaning ascribed them agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party understand agree that exhibit nbsp attached this amendment forth table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign those target that were subject active program have become abandoned program operation this amendment otherwise thus date first written above continue give rise discovered rnai compound collaboration product licensed product under agreement collectively nbsp active program target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign those target that novartis previously obtained continues have date first written above including after this amendment into effect right forth section nbsp agreement collectively nbsp novartis section nbsp nbsp target table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment under rule security exchange style page break before always size style color width align center style margin margin bottom font size font family time roman align right small xecution small small ersion small style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party understand agree that target listed exhibit nbsp operation this amendment date first written above longer come within scope novartis license other right under agreement each such target will hereafter treated nbsp abandoned program thereunder further consequence forth section nbsp agreement will hereafter apply such target collectively former active program target table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign milestone payment table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party understand agree that payment amount forth first table section nbsp will payable alnylam tenth business after date first written above which will creditable against such from such such corresponding milestone event achieved thereafter creditable against other payment payable novartis alnylam under agreement such payment will made novartis alnylam without deduction reduction right kind notwithstanding other contrary term agreement subsequent event table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign consideration foregoing payment made novartis alnylam party hereby agree additional term forth exhibit nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign other amendment table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign definition alnylam know hereby deleted entirety replaced with following font style white space nowrap alnylam nbsp know font shall mean know first controlled alnylam before march nbsp expressly excluding know first controlled alnylam thereafter including broad rnai know table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign definition broad rnai know clause know future controlled alnylam hereby deleted entirety replaced with following know first controlled alnylam before march nbsp expressly excluding know first controlled alnylam thereafter table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign definition alnylam patent right hereby deleted entirety replaced with following alnylam patent right shall mean nbsp patent right first controlled alnylam before march nbsp expressly excluding patent right first controlled alnylam thereafter except those claim patent right expressly included following clause nbsp nbsp claim patent right first controlled alnylam after march nbsp extent that nbsp those patent right claim priority nbsp those claim fully supported enabled each case nbsp such patent right first controlled before march nbsp included foregoing clause nbsp alnylam patent right will include broad rnai patent right table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment under rule security exchange style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align right small xecution small small ersion small style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign definition broad rnai patent right clause shall mean patent right listed schedule patent licensed alnylam under listed alnylam third party agreement other patent future controlled alnylam that cover hereby deleted entirety replaced with following shall mean nbsp patent right listed schedule nbsp nbsp patent licensed alnylam under listed alnylam third party agreement nbsp other patent right each case through nbsp extent first controlled alnylam before march nbsp expressly excluding patent right first controlled alnylam thereafter except those claim patent right expressly included following clause nbsp nbsp claim patent right first controlled alnylam after march nbsp extent that nbsp those patent right claim priority nbsp those claim fully supported enabled each case nbsp such patent right first controlled before march nbsp included foregoing clause nbsp each case nbsp that cover table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign each section agreement hereby deleted entirety each hereby replaced with following intentionally omitted table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign exhibit nbsp forth additional reporting obligation novartis table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign following hereby added between section nbsp foregoing license sublicensed novartis subject conditioned upon following table style margin margin bottom margin left font size font family time roman nbsp such sublicense complies full with subject section nbsp clause nbsp thereof such sublicensee will have right grant further sublicenses style margin margin bottom margin left font size font family time roman nbsp selected target those rnai compound licensed product containing such rnai compound against such selected target sublicensed only novartis least rnai compound against such selected target clarity rnai compound licensed product containing such rnai compound sublicensed only novartis such rnai compound novartis another rnai compound against same selected target such first rnai compound style margin margin bottom margin left font size font family time roman nbsp total number such sublicenses novartis under such license exceed clarity such sublicense apply more than such selected target corresponding rnai compound licensed product containing such rnai compound style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment under rule security exchange style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align right small xecution small small ersion small style margin margin bottom font size nbsp style margin margin bottom margin left font size font family time roman nbsp least before granting such sublicense option other right such sublicense novartis will notify alnylam writing identity such proposed sublicensee nbsp sublicensee notice within after receiving such sublicensee notice from novartis alnylam will notify novartis whether alnylam then dispute with such proposed sublicensee reasonable ground believing that proposed sublicensee practicing know patent right including alnylam intellectual property owned licensed alnylam collaborator their respective affiliate without valid license other authorization without reference safe harbor other defense under counterpart under event alnylam reasonably belief such sublicensee practicing such know patent right without valid license other authorization shall have right object writing such sublicensee setting forth reasonable substantiation supporting objection that event novartis will grant sublicense such sublicensee style margin margin bottom margin left font size font family time roman novartis receive notice from alnylam described subsection nbsp above within after alnylam receipt sublicensee notice from novartis then novartis notify alnylam that receive objection from alnylam ground permitted above within business will proceed with proposed sublicense provided that novartis will resubmit proposed sublicensee alnylam such sublicense granted within initial sublicensee notice being received alnylam even proposed sublicensee same nbsp novartis will provide alnylam copy agreement containing such sublicense granted option other right such sublicense granted provided that novartis redact financials from such agreement style margin margin bottom margin left font size font family time roman nbsp such sublicensee will commit condition such sublicense commercially reasonable effort with reference party such definition referring such sublicensee nbsp collaboration product referring rnai compound licensed product containing such rnai compound develop commercialize rnai compound licensed product containing such rnai compound that subject such sublicense such obligation will selected target selected target basis rnai compound against more than selected target subject such sublicense such sublicensee fails comply with foregoing diligence obligation then novartis will notify alnylam such failure terminate such sublicense relevant selected target upon alnylam written request style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment under rule security exchange style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align right small xecution small small ersion small style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign updated notice address table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign alnylam hereby designates following corrected notice address under section nbsp agreement table style margin margin bottom margin left font size font family time roman alnylam style margin margin bottom margin left font size font family time roman alnylam pharmaceutical style margin margin bottom margin left font size font family time roman third street floor style margin margin bottom margin left font size font family time roman cambridge massachusetts style margin margin bottom margin left font size font family time roman attention nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp general counsel style margin margin bottom margin left font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style margin margin bottom margin left font size font family time roman with copy which shall constitute notice style margin margin bottom margin left font size font family time roman goodwin procter style margin margin bottom margin left font size font family time roman state street style margin margin bottom margin left font size font family time roman boston style margin margin bottom margin left font size font family time roman attention nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp kingsley taft style margin margin bottom margin left font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign novartis hereby designates following corrected notice address under section nbsp agreement table style margin margin bottom margin left font size font family time roman novartis style margin margin bottom margin left font size font family time roman novartis institute biomedical research style margin margin bottom margin left font size font family time roman massachusetts avenue style margin margin bottom margin left font size font family time roman cambridge massachusetts style margin margin bottom margin left font size font family time roman attention nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp general counsel style margin margin bottom margin left font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign general term table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign except expressly amended hereby remaining term agreement will remain fall force effect table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign event conflict between provision agreement this amendment provision this amendment will govern control table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign agreement amended this amendment constitutes entire agreement between alnylam novartis with respect subject matter contained this amendment therein supersedes previous agreement whether written oral table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment under rule security exchange style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align right small xecution small small ersion small style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign this amendment will governed interpreted under effect commonwealth massachusetts excluding conflict principle table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign this amendment executed counterpart each which counterpart when executed delivered will deemed original which counterpart taken together will constitute same instrument even both party have executed same counterpart signature provided facsimile transmission will deemed original signature table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign under applicable provision this amendment invalid unenforceable otherwise directly indirectly affect validity other material provision agreement severed amendment clause then mutually agreed that this amendment will endure except severed clause party will consult their best effort agree upon valid enforceable provision which will reasonable substitute such severed amendment clause light intent this agreement table style margin margin bottom font size font family time roman align center remainder page intentionally left blank style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment under rule security exchange style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center style page break before always size style color width align center style margin margin bottom font size font family time roman align right small xecution small small ersion small style margin margin bottom font size nbsp style margin margin bottom text indent font size font family time roman witness whereof alnylam novartis have caused this amendment duly executed their authorized representative date first written above style font size margin margin bottom nbsp align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign colspan alnylam pharmaceutical style font size height height colspan style font family time roman font size valign valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman john maraganore style font family time roman font size valign name valign bottom valign bottom john maraganore style font family time roman font size valign title valign bottom valign bottom chief executive officer style font size height colspan style font family time roman font size valign colspan novartis institute style font family time roman font size valign colspan biomedical research style font size height height colspan style font family time roman font size valign valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman scott brown style font family time roman font size valign name valign bottom valign bottom scott brown style font family time roman font size valign title valign bottom valign bottom general counsel table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment under rule security exchange style page break before always size style color width align center style margin margin bottom font size font family time roman align right small xecution small small ersion small style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit nbsp style margin margin bottom font size font family time roman align center active program target novartis section nbsp target style margin margin bottom font size font family time roman active program target style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman novartis section nbsp target style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment under rule security exchange style page break before always size style color width align center style margin margin bottom font size font family time roman align right small xecution small small ersion small style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit nbsp style margin margin bottom font size font family time roman align center former active program target former novartis section nbsp target style margin margin bottom font size font family time roman former active program target style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign party understand agree that become abandoned program prior this amendment have included here sake completeness table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment under rule security exchange style page break before always size style color width align center style margin margin bottom font size font family time roman align right small xecution small small ersion small style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit nbsp style margin margin bottom font size font family time roman align center additional term style margin margin bottom font size font family time roman party understand agree that style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party agree that section nbsp agreement permit novartis assign agreement third party connection with sale transfer substantially novartis business developing commercializing rnai product notwithstanding continued business novartis using table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment under rule security exchange style page break before always size style color width align center style margin margin bottom font size font family time roman align right small xecution small small ersion small style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center additional novartis reporting obligation style margin margin bottom font size font family time roman once calendar year around december nbsp novartis shall submit report alnylam that contains following information style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman certain confidential portion this exhibit were omitted replaced with complete version this exhibit been filed separately with secretary security exchange commission pursuant application requesting confidential treatment under rule security exchange body html text document